ChemoCentryx Up 70%, Lead Drug Meets Phase II Objective
December 12, 2014 at 10:37 AM EST
ChemoCentryx Inc (NASDAQ: CCXI) gained more than 70 percent Friday on news that its lead drug candidate met with success in a Phase ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.